Therapy News and Research

RSS

Lyra Therapeutics announces presentation of Phase 1 clinical data for LYR-210 in CRS patients

Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat diseases, today announced the presentation of Phase 1 clinical data for the company's lead therapeutic, LYR-210, for chronic rhinosinusitis, a debilitating disease caused by inflammation of the paranasal sinus tissues that affects approximately 27 million people, or 11% of the adult population in the U.S.

8 Oct 2018

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the National Comprehensive Cancer Network added COPIKTRA (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines) for follicular lymphoma.

8 Oct 2018

Damage to small nerves shown to be cause of chronic pain following knee surgeries

Patients frequently experience severe chronic pain following knee operations. Although the pain is thought to be due to damage to small nerves, it was hitherto impossible to demonstrate this by imaging.

8 Oct 2018

Immunotherapy effective for individuals with inherited form of skin cancer

Individuals with an inherited form of skin cancer often have a poor prognosis. The type of immunotherapy that was awarded this year's Nobel Prize in Physiology or Medicine is, however, particularly effective in this patient group, research from Karolinska Institutet in Sweden shows. The study is published in the Journal of Medical Genetics.

8 Oct 2018

Study highlights opposite effects of gene following different types of environmental events

Researchers have discovered that the same gene which increases your risk of depression following financial stress as you grow older also reduces your chance of depression associated with friendship and relationships stresses when young- your social network.

8 Oct 2018

Nonfatal injuries in the U.S. cost over $1.8 trillion in 2013

A new analysis by researchers from Brown University and the Pacific Institute for Research and Evaluation has found that nonfatal injuries in the U.S. in the year 2013 cost more than $1.8 trillion.

8 Oct 2018

T-CALM Phase 2 clinical study results offer hope for essential tremor patients

Cavion, Inc., a leading clinical stage biotechnology company committed to developing novel therapeutics for people with neurological diseases, today announced promising results of the T-CALM Phase 2 clinical trial of its first-in-class T-type calcium channel modulator CX-8998 in essential tremor.

7 Oct 2018

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.

7 Oct 2018

Health insurers have inconsistent policy terms for non-drug pain treatments, study finds

Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating lower back pain, a study led by researchers at Johns Hopkins Bloomberg School of Public Health has found.

6 Oct 2018

Researchers develop cancer vaccine platform to improve efficacy of oncolytic enveloped viruses

Researchers at the Faculty of Pharmacy have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses currently in clinical use.

6 Oct 2018

Simple cleaning procedure reduces MRSA transmission from therapy dogs to children with cancer

Therapy dogs help ease stress in young patients with cancer, but can spread methicillin-resistant Staphylococcus aureus, putting vulnerable kids at risk for a serious infection.

5 Oct 2018

New method for studying the cell nucleus could improve disease detection

Researchers at New York University have found a way to measure the physical properties of the nucleus and its constituents in live human cells.

5 Oct 2018

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

5 Oct 2018

Researchers receive DoD grant to test efficacy of stem cell therapy for eye injuries

Researchers at the University of Illinois at Chicago have received a four-year, $5.25 million grant from the U.S. Department of Defense to lead a multi-site clinical trial to test the efficacy of a stem cell-based treatment for eye injuries.

5 Oct 2018

Study demonstrates benefits of using triple dual therapies in patients with COPD

The InforMing the PAthway of COPD Treatment study was conducted to assess the benefits of triple versus dual therapy in patients with COPD.

5 Oct 2018

Study reveals factors linked to the development of Crohn's disease

How cells talk to each other, and what they say, has long held fascination for Seema Khurana, professor of biology and biochemistry.

5 Oct 2018

Scientists receive Young Investigator Grants from Brain & Behavior Research Foundation

The Brain & Behavior Research Foundation today announced the awarding of its Young Investigator Grants valued at more than $13.8 million to 200 of the world's most promising young scientists.

5 Oct 2018

FDA approves HEMLIBRA for treatment of hemophilia A

Chugai Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by Chugai, for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors, administered once weekly, every two weeks, or every four weeks.

5 Oct 2018

New approach could lead to precise treatments for traumatic brain injury

Traumatic head injury can have widespread effects in the brain, but now scientists can look in real time at how head injury affects thousands of individual cells and genes simultaneously in mice.

5 Oct 2018

Depressed women with sexual abuse histories benefit from Interpersonal Psychotherapy-Trauma

Women sexually abused in childhood and adolescence who suffer from depression and post-traumatic stress disorder benefit significantly from Interpersonal Psychotherapy-Trauma, according to a Rutgers researcher.

4 Oct 2018

Therapy News and Research

Lyra Therapeutics announces presentation of Phase 1 clinical data for LYR-210 in CRS patients

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Damage to small nerves shown to be cause of chronic pain following knee surgeries

Immunotherapy effective for individuals with inherited form of skin cancer

Study highlights opposite effects of gene following different types of environmental events

Nonfatal injuries in the U.S. cost over $1.8 trillion in 2013

T-CALM Phase 2 clinical study results offer hope for essential tremor patients

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Health insurers have inconsistent policy terms for non-drug pain treatments, study finds

Researchers develop cancer vaccine platform to improve efficacy of oncolytic enveloped viruses

Simple cleaning procedure reduces MRSA transmission from therapy dogs to children with cancer

New method for studying the cell nucleus could improve disease detection

Researchers identify sex-specific genetic risk factor for pancreatic cancer

Researchers receive DoD grant to test efficacy of stem cell therapy for eye injuries

Study demonstrates benefits of using triple dual therapies in patients with COPD

Study reveals factors linked to the development of Crohn's disease

Scientists receive Young Investigator Grants from Brain & Behavior Research Foundation

FDA approves HEMLIBRA for treatment of hemophilia A

New approach could lead to precise treatments for traumatic brain injury

Depressed women with sexual abuse histories benefit from Interpersonal Psychotherapy-Trauma

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News